Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple reminder curb antibiotic overuse?

NCT ID NCT06436690

Knowledge-focused Sponsor: Penn State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests two low-cost methods to help junior doctors in India prescribe antibiotics only when needed. One method requires doctors to write the diagnosis on the prescription; the other gives them feedback on their prescribing habits. The goal is to reduce unnecessary antibiotic use and fight antimicrobial resistance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide low-cost ways to reduce unnecessary antibiotic prescriptions, helping slow antimicrobial resistance.
What could go wrong
This is a small, early-stage behavioral study with 56 physicians, so results may not apply broadly. It tests reminders and feedback, not a new drug or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

62 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

For physicians: Inclusion criteria: * age 18+ * working at an outpatient clinic in one of the participating hospitals. Exclusion criteria: * \<18 years of age * working at more than one of the participating hospitals For patients: Inclusion criteria: * age 18+ * sought care at one of the outpatient clinics in the participating hospitals. Exclusion criteria: * \<18 years of age * one of the vulnerable populations (pregnant women, cognitively impaired adults)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antimicrobial resistance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Antimicrobial resistance

Contacts and locations

Locations

  • Institute for Social and Environmental Research - Nepal

    Bharatpur, Bagmati, 44200, Nepal

  • Pennsylvania State University

    University Park, Pennsylvania, 16801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.